MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-17-2026
Boston Scientific Corporation Cash Conversion Cycle 2011-2026 | BSX
Annual Cash Conversion Cycle Boston Scientific Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107 | 118 | 107 | 84 | 81.3 | 98.8 | 187 | 166 | 140 | 141 | 198 | 171 | 176 | 163 | 160 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 198 | 81.3 | 140 |
Quarterly Cash Conversion Cycle Boston Scientific Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114 | 105 | 116 | 123 | 120 | 118 | 117 | 109 | 95.9 | - | 45.9 | 46.9 | 88.7 | - | 84.7 | 74 | 83.2 | - | 88 | 96.7 | 106 | - | 122 | 125 | 116 | - | 111 | 101 | 92.7 | - | 78.5 | 79.1 | 74.1 | - | 78 | 72.5 | 105 | - | 137 | 136 | 131 | - | 113 | 111 | 113 | - | 116 | 112 | 103 | - | 107 | 103 | 99.8 | - | 97.7 | 96.6 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 137 | 45.9 | 101 |
Cash Conversion Cycle of other stocks in the Medical devices industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Delcath Systems
DCTH
|
258 | $ 9.11 | -10.77 % | $ 260 M |  USA |
 |
Acutus Medical
AFIB
|
761 | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
271 | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
104 | - | - | $ 1.77 B | USA |
 |
Apollo Endosurgery
APEN
|
156 | - | - | $ 475 M | USA |
 |
Lianluo Smart Limited
LLIT
|
94.1 | - | 24.59 % | $ 44.8 M |  China |
 |
Alphatec Holdings
ATEC
|
240 | $ 13.94 | -0.71 % | $ 2.09 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
174 | - | -5.86 % | $ 30.6 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
-4.41 | $ 7.0 | 5.74 % | $ 503 M |  Israel |
 |
EDAP TMS S.A.
EDAP
|
163 | $ 4.38 | -4.58 % | $ 163 M |  France |
 |
Axonics Modulation Technologies
AXNX
|
299 | - | - | $ 3.31 B | USA |
 |
Avinger
AVGR
|
335 | - | -20.74 % | $ 369 K | USA |
 |
Apyx Medical Corporation
APYX
|
246 | $ 3.49 | 2.05 % | $ 121 M | USA |
 |
AxoGen
AXGN
|
245 | $ 31.87 | 2.07 % | $ 1.47 B | USA |
 |
Aziyo Biologics
AZYO
|
111 | - | 1.37 % | $ 20.5 M | USA |
 |
Bio-Rad Laboratories
BIO
|
263 | $ 275.33 | 2.19 % | $ 7.77 B | USA |
 |
BIOLASE
BIOL
|
129 | - | -13.19 % | $ 166 K | USA |
 |
Bruker Corporation
BRKR
|
227 | $ 40.88 | 2.48 % | $ 6.09 K | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
InMode Ltd.
INMD
|
234 | $ 14.0 | 0.29 % | $ 905 M | Israel |
 |
CryoLife, Inc.
CRY
|
183 | - | -4.14 % | $ 702 M | USA |
 |
Conformis
CFMS
|
165 | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
240 | $ 14.09 | -7.06 % | $ 381 M | USA |
 |
CONMED Corporation
CNMD
|
212 | $ 45.89 | -0.18 % | $ 1.42 B | USA |
 |
Soliton, Inc.
SOLY
|
-67.9 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-227 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
81.2 | - | - | $ 111 M |  Canada |
 |
Cardiovascular Systems
CSII
|
172 | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
404 | - | -10.19 % | $ 1.99 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-13.9 | $ 2.48 | 1.02 % | $ 146 M | Israel |
 |
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | USA |
 |
Dynatronics Corporation
DYNT
|
80.5 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
32.7 | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
180 | $ 24.18 | 1.09 % | $ 204 M | USA |
 |
Establishment Labs Holdings
ESTA
|
355 | $ 77.41 | -1.12 % | $ 2.18 B |  Costa-rica |
 |
Second Sight Medical Products
EYES
|
-21 | - | -0.97 % | $ 54.4 M | USA |
 |
FONAR Corporation
FONR
|
234 | $ 18.53 | -0.3 % | $ 121 M | USA |
 |
GBS
GBS
|
204 | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
314 | $ 96.27 | 0.06 % | $ 13 B | USA |
 |
Tandem Diabetes Care
TNDM
|
249 | $ 26.14 | 0.5 % | $ 1.78 B | USA |
 |
Helius Medical Technologies
HSDT
|
18.2 | $ 2.11 | -2.76 % | $ 1.28 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
222 | $ 11.13 | -4.01 % | $ 857 M | USA |
 |
Cytosorbents Corporation
CTSO
|
50.6 | $ 0.73 | 2.57 % | $ 39.7 M | USA |
 |
Inogen
INGN
|
55.8 | $ 6.4 | 6.53 % | $ 151 M | USA |
 |
IRIDEX Corporation
IRIX
|
119 | $ 1.47 | -2.0 % | $ 23.7 M | USA |
 |
IRadimed Corporation
IRMD
|
267 | $ 102.4 | 1.89 % | $ 1.3 B | USA |